Paul D. Fey, Ph.D.

Department Affiliations
Medical Director, Nebraska Medical Center Microbiology Section

Staphylococcal biology and pathogenesis, antibiotic resistance of clinical relevant pathogens
For more details on Dr. Fey's research, please visit his webpage.

Education and Training
B.S., Kansas State University, 1990 (Biology and Microbiology)
Ph.D., Creighton University, 1995 (Medical Microbiology)
Post-Doctoral Fellowship, Medical College of Virginia, 1995-1997
Diplomat American Board of Medical Microbiology D(ABMM), 2012 

Teaching Activities
Course coordinator/director: 

PAMM950 Bacterial Pathogenesis 

PAMM 871 Antibiotics-Mechanism of Action and Resistance 

PAMM 950 Topics in Staphylococcal Biology

Faculty advisor:
Four Ph.D. students 

Medical Students - Streptococcal infections 

Direct clinical microbiology rounds for Infectious Disease/Pathology residents and fellows

National Activities
Member: American Society for Microbiology
Editorial Board: Antimicrobial Agents and Chemotherapy
2013:  NIH CRFS Clinical Research and Field Studies of Infectious Diseases study section
2013: International Symposium for Staphylococci and Staphylococcal Infections (ISSSI)-2014 Scientific Advisory Board
2013:  Chair.  NIH/NIAID ZRG1 IDM-V (12) B Small Business Non-HIV Diagnostics, Food Safety, Sterilization/Disinfection and Bioremediation.
2013:  NIH/NIAID ZAI1 EC-M (M1) 1 "OMICS" Technologies for Predictive Modeling of Infectious Diseases (U19)
2013:  NASA Space Biology Microbiology Review Panel
2006-2013: NIH NIAID Study Section ZRG IDM-M (12) “Food Safety, non-HIV Infectious Agents Sterilization and Bioremediation”
2012: Joint IDSA/ATS guidelines committee for HAP/VAP therapy
2012: State of Pennsylvania Department of Health-Antibiotic Resistance Study section.
2011: Reviewer of graduate program (M.S., Ph.D., M.D./Ph.D.) of the University of South Dakota Sanford School of Medicine.
2011: DMRDP Study Section. Clinical Trials of Infectious Disease
2011: NIAID ZRG IDM-B (02) M Study Section. Microbial Pathogens
2010: USDA Agriculture and Food Research Initiative (AFRI). Addressing critical and emerging food safety issues. Study section. 
2010: MRC (Medical Research Council)-United Kingdom. Expert reviewer
2010: NIAID PCMB Study Section. Ad-Hoc Member.
2009-2011: NIAID BACP Study section. Ad-Hoc Member.

Widhelm, T. J., Yajjala, V. K., Endres, J. L., Fey, P. D., & Bayles, K. W. (2014). Methods to Generate a Sequence-Defined Transposon Mutant Library in Staphylococcus epidermidis Strain 1457. In Staphylococcus Epidermidis (pp. 135-142). Humana Press.

Goering, R. V., & Fey, P. D. (2014). Pulsed Field Gel Electrophoresis of Staphylococcus epidermidis. In Staphylococcus Epidermidis (pp. 55-60). Humana Press.

Roberts, A. L., Hewlett, A. L., Yu, J., Nahm, M. H., Fey, P. D., & Iwen, P. C. (2013). Streptococcus pneumoniae serotype 6C presenting as recurrent prosthetic knee joint infection in a patient with a history of congenital asplenia and underlying autoimmune disease: a case report and literature review. Diagnostic microbiology and infectious disease77(4), 376-379.

Buss, S. N., Alter, R., Iwen, P. C., & Fey, P. D. (2013). Implications of Culture-Independent Panel-Based Detection of Cyclospora cayetanensisJournal of clinical microbiology51(11), 3909-3909.

V. C. Thomas, L. C. Kinkead, A. Janssen, C. R. Schaeffer, K. M. Woods, J. K. Lindgren, J. M. Peaster, S. S. Chaudhari, M. Sadykov, J. Jones, S. M.Mohamadi AbdelGhani, M. C. Zimmerman, K. W. Bayles, G. A. Somerville, and P. D. Fey.  2013. A dysfunctional TCA cycle enhances fitness of Staphylococcus epidermidis during β-lactam stress. mBio. 4(4) doI:10.1128    

C. Gries, J.L. Bose, A. Nuxoll, P.D. Fey, and K.W. Bayles.  2013.  The Ktr Potassium Transport System in Staphylococcus aureus and its Role in Cell Physiology, Antimicrobial Resistance, and Pathogenesis.  Mol Microbiol 89:760-773. 

K.A. Bryant, A.L. Roberts, M.E. Rupp, J.R. Anderson, E.R. Lyden, P.D. Fey, and T.C. Van Schooneveld. 2013.  Susceptibility of Enterococci to daptomycin is Dependent upon testing Methodology. Diag Microbiol Infect Dis. 76:497-501

D.E. Moormeier, J.L. Endres, E.E. Mann, M.R. Sadykov, A.R. Horswill, K.C. Rice, P.D. Fey, and K.W. Bayles.  2013.  Use of microfluidics technology to analyze gene expression during Staphylococcus aureus biofilm formation reveals distinct physiological niches.  Appl Environ Microbiol. 79:3413-24

J. L. Bose, P. D. Fey, and K. W. Bayles.  2013.  Genetic tools to enhance the study of gene function and regulation in Staphylococcus aureus.  Appl. Environ. Microbiol. 79:2218-24.

P.D. Fey, J. L. Endres, V.K. Yajjala, T.J. Widhelm, R.J. Boissy, J.L. Bose, and K.W. Bayles.  2013. A Genetic Resource for Rapid and Comprehensive Phenotype Screening of Non-essential Staphylococcus aureus Genes.  mBio 4(1):e00537-12.  Comment:  N.D. Hammer and E.P. Skaar.  2013.  Powerful Genetic Resource for the Study of Methicillin-Resistant Staphylococcus aureus.  mBio 4(2).

M.E. Rupp, T. Huerta, S. Yu, R.J. Cavalieri, R. Alter, P.D. Fey, E. Lyden, and T. Van Schooneveld.  2013.  Hospital Basins used to Administer Chlorhexidine Baths are unlikely Microbial Reservoirs.  Infect. Control Hosp. Epidemiol. 34:643-645.

M. A. Larson, Shi-Jian Ding, S. R. Slater, A. Hanway, A. M. Bartling, P. D. Fey, O. Lockridge, S. C. Francesconi, S. H. Hinrichs.  2013.  Application of Chromosomal DNA and Protein Targeting for the Identification of Yersinia pestis. Prot. Clin App. 7:416-423.

K.A. Bryant, T.C. Van Schooneveld, I. Thapa, D. Bastola, L.O. Williams, T.J. Safranek, S.H. Hinrichs, M.E. Rupp, and P.D. Fey.  2013.  KPC-4is encoded within a truncated Tn4401 in an IncL/M plasmid pNE1280 isolated from Enterobacter cloacae and Serratia marcescens. Antimicrob. Agents Chemother. 57(1):37-41  

For a detailed list of publications, click here.




Paul D. Fey, Ph.D.
Dr. Paul D. Fey
Email Address

Mailing Address
985900 Nebraska Medical Center
Omaha, NE 68198-5900

Office Address
DRC2 7028

Laboratory Address
DRC2 7028/7042

Phone Numbers
Office: 402-559-2122
Lab: 402-559-8104